A groundbreaking NHS trial is testing an artificial intelligence blood test that could replace invasive transvaginal ultrasound scans for some women undergoing cancer screening—potentially sparing thousands from an uncomfortable procedure.

The innovative test is being trialled by two NHS trusts and represents a significant step forward in making cancer detection more patient-friendly while maintaining accuracy. If successful, it could transform the screening experience for women across the country, removing a major barrier that has led some to avoid these potentially life-saving checks. Read the full story →

Today's takeaway: Technology that makes healthcare less invasive and more accessible can encourage more people to seek the screenings that save lives.